Clinical Trial Results: Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain [NA]

View source ↗

Summary

Completed clinical trial investigating cholinergic anti-inflammatory pathway to treat systemic lupus erythematosus–related musculoskeletal pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain
• Systemic Lupus Erythematosus

Snippet

Sponsor: Northwell Health | Conditions: Lupus Erythematosus, Systemic, Musculoskeletal Pain | NA | Status: COMPLETED | Results posted: 2026-07-08